Functional Outcomes and Morbidity in Pediatric Sepsis Survivors: A Tanzanian Experience

Sarah A Lau-Braunhut1,2, Audrey M Smith3, Martina A Steurer2

  • 1Department of Pediatric Critical Care, Banner Children's at Desert Hospital, Mesa, AZ, United States.

Frontiers in Pediatrics
|February 3, 2022
PubMed

Insights

Pediatric sepsis survivors in Tanzania showed low functional decline via the adapted Functional Status Scale (FSS). However, guardians reported more children not recovered, indicating FSS limitations in resource-limited settings.

Area of Science:

  • Global Health
  • Pediatrics
  • Infectious Diseases

Background:

  • Pediatric sepsis causes significant childhood morbidity and mortality, especially in resource-limited settings.
  • Understanding post-sepsis functional outcomes is crucial as survival rates increase.
  • The Functional Status Scale (FSS) measures functional impairment but hasn't been studied in non-critically ill pediatric sepsis survivors in resource-limited areas.

Purpose of the Study:

  • To evaluate morbidity in pediatric sepsis survivors using a modified Functional Status Scale (FSS) in a resource-limited setting in Tanzania.
  • To assess functional outcomes in children with sepsis, including those not critically ill.

Main Methods:

  • A prospective cohort study was conducted in Tanzania over 12 months, enrolling children aged 28 days to 14 years with sepsis.
  • The FSS was adapted for local resources, and guardian interviews were conducted at baseline and 28-day follow-up.
  • Primary outcome was defined as a decline in functional status (change in FSS score ≥ 3).

Main Results:

  • Of 1,359 survivors, 4.3% showed a decline in functional status per the adapted FSS.
  • Conversely, 13.8% of guardians reported their child had not returned to their pre-illness state.
  • A significant proportion (three-quarters) of children subjectively not recovered were missed by the FSS.

Conclusions:

  • The adapted FSS indicated a low rate of functional decline in pediatric sepsis survivors in this Tanzanian cohort.
  • Subjective guardian reports revealed a higher burden of non-recovery, highlighting FSS limitations in this context.
  • Further revision and validation of the FSS are needed to better capture functional outcomes in resource-limited settings.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
510
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
260
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
372
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
581
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11